K R Chaudhuri Selected Research

Lofepramine (Lomont)

9/2002	A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the "Cari Loder regime") in the treatment of multiple sclerosis.
7/2001	MRI changes in multiple sclerosis following treatment with lofepramine and L-phenylalanine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

K R Chaudhuri Research Topics

Disease

10	Parkinson Disease (Parkinson's Disease) 01/2018 - 02/2000
3	Dyskinesias (Dyskinesia) 11/2017 - 07/2002
3	Huntington Disease (Huntington's Disease) 08/2008 - 02/2000
3	Parkinsonian Disorders (Parkinsonism) 08/2001 - 01/2000
3	Multiple System Atrophy 03/2001 - 01/2000
2	Constipation 01/2018 - 03/2010
2	Multiple Sclerosis 09/2002 - 07/2001
2	Chorea (Rheumatic Chorea) 08/2001 - 02/2000
2	Autonomic Nervous System Diseases (Dysautonomia) 08/2001 - 02/2000
1	Pain (Aches) 01/2018
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 10/2016
1	Erectile Dysfunction 03/2010
1	Sialorrhea 03/2010
1	Hallucinations (Hallucination) 09/2008
1	Tremor (Tremors) 09/2008
1	Fibrosis (Cirrhosis) 09/2008
1	Restless Legs Syndrome (Restless Legs) 07/2002
1	Dystonic Disorders (Writer's Cramp) 01/2002
1	Blepharospasm 01/2002
1	Torticollis (Wryneck) 08/2001
1	Primary Cervical Dystonia 08/2001
1	Complex Regional Pain Syndromes 08/2001
1	Dystonia (Limb Dystonia) 08/2001
1	Movement Disorders (Movement Disorder) 08/2001
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2001
1	Nervous System Paraneoplastic Syndromes 04/2001
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2001
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2000
1	Hypokinesia (Bradykinesia) 01/2000
1	Lewy Body Disease (Lewy Body Dementia) 01/2000
1	Cognitive Dysfunction 01/2000

Drug/Important Bio-Agent (IBA)

7	Levodopa (L Dopa)FDA LinkGeneric 11/2017 - 01/2000
4	Dopamine Agonists (Dopamine Agonist)IBA 10/2016 - 01/2001
3	Dopamine Receptors (Dopamine Receptor)IBA 07/2002 - 08/2001
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2018 - 08/2001
2	Phenylalanine (L-Phenylalanine)FDA Link 09/2002 - 07/2001
2	Lofepramine (Lomont)IBA 09/2002 - 07/2001
2	Cabergoline FDA LinkGeneric 07/2002 - 01/2001
1	Opiate AlkaloidsIBA 01/2018
1	Analgesics (Analgesic Drugs)IBA 01/2018
1	ioflupaneIBA 01/2018
1	rotigotine FDA Link 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Oxycodone (Oxycontin)FDA LinkGeneric 01/2018
1	Carbidopa (Lodosyn)FDA LinkGeneric 11/2017
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 03/2010
1	Sildenafil Citrate (Viagra)FDA Link 03/2010
1	Botulinum Toxins (Botulinum Toxin)IBA 03/2010
1	amsonic acid (DAS)IBA 09/2008
1	Antidepressive Agents (Antidepressants)IBA 09/2002
1	VitaminsIBA 09/2002
1	Dopamine (Intropin)FDA LinkGeneric 07/2002
1	Dopamine Agents (Dopaminergic Agents)IBA 07/2002
1	HLA-DR13 antigenIBA 08/2001
1	Dopamine D5 ReceptorsIBA 08/2001
1	fluorodopa F 18IBA 05/2001
1	Proteins (Proteins, Gene)FDA Link 04/2001
1	RNA (Ribonucleic Acid)IBA 04/2001
1	Apomorphine FDA Link 03/2001
1	Erythropoietin FDA Link 03/2001
1	Pramipexole (Mirapex)FDA LinkGeneric 01/2001
1	Adenosine Triphosphate (ATP)IBA 02/2000
1	Dihydroxyphenylalanine (Dopa)IBA 02/2000
1	Glucose (Dextrose)FDA LinkGeneric 02/2000
1	Phosphorus (Red Phosphorus)IBA 02/2000
1	Deoxyglucose (2 Deoxy D glucose)IBA 02/2000
1	NeurotoxinsIBA 01/2000
1	EnzymesIBA 01/2000

Therapy/Procedure

6	Therapeutics 01/2018 - 01/2001
1	Transplantation 08/2008
1	Injections 09/2002
1	Sympathectomy (Sympathectomies) 08/2001